Arrayit Corporation Announces Allergy Testing Services Agreement with a Major Health and Wellness Provider
December 03 2018 - 5:30AM
Sunnyvale, Dec. 03, 2018 (GLOBE NEWSWIRE) --
Arrayit Corporation (OTC: ARYC), a life sciences and
personalized medicine company, announces a new allergy testing
services agreement with a major healthcare company specializing in
patient health and wellness. Arrayit offers simple non-invasive
testing services that measure reactivity of immunoglobulin E (IgE)
antibodies to an extensive panel of food, environmental and
specialty allergens as a precision healthcare solution to assist
physicians in the diagnosis and treatment of allergy and asthma.
The healthcare leader provides health and pharmacy services to more
than 10 million retail, commercial and corporate customers and
reports revenues exceeding $35,000,000,000 ($35 billion dollars)
annually.
Arrayit recently completed an allergy testing
pilot program for a top retail chain, established a nationwide
network of 1,700 allergy sales professionals, met with top
officials at the United States Food and Drug Administration (FDA)
regarding approval of a major product line, signed allergy testing
contracts with a consortium of 178 medical clinics, received
approval for in-store promotions by a major retailer, announced
allergy testing partnerships with major allergy therapeutics
providers, received approval for direct Medicare billing by the
Centers for Medicare and Medicaid Services (CMS), reported the sale
and shipping of clinical instrumentation to the FDA, launched
the Patient Data Solutions allergy portal for doctors and clinics,
and celebrated 25 years of company operations. Adding a major new
payor in the health and wellness sector expands Arrayit’s allergy
testing footprint among healthcare recipients in both the
government and commercial health insurance markets.
Chief Executive Officer Rene Schena states, “We
are pleased to announce a new allergy testing services agreement
with a major healthcare provider. The provider’s focus on lifelong
well-being through the deployment of transformative healthcare
solutions aligns perfectly with our miniaturized, multiplexed and
highly automated allergy testing services that deliver personalized
medical information consistent with preventative health and
wellness models.”
About Arrayit
Arrayit Corporation, headquartered in Sunnyvale, California, leads
and empowers the research, biotechnology, pharmaceutical, clinical
and healthcare sectors through the discovery, development and
manufacture of proprietary life science and personalized medicine
products and services to advance biomedical research and improve
wellness and human health. Please
visit www.arrayit.com for more information.
Safe Harbor Statement
We have identified forward-looking statements by using words such
as "expect", "believe", and "should". Although we believe our
expectations are reasonable, our operations involve a number of
risks and uncertainties that are beyond our control, and these
statements may turn out not to be true. Risk factors associated
with our business, including some of the facts set forth herein,
are detailed in the Company's public filings.
CONTACT
Public Relations
Arrayit Corporation
Tel: 408-744-1331
Email: arrayit@arrayit.com
Web: www.arrayit.com
CONTACT
Public Relations
Arrayit Corporation
Tel: 408-744-1331
Email: arrayit@arrayit.com
Web: www.arrayit.com
Arrayit (CE) (USOTC:ARYC)
Historical Stock Chart
From Oct 2024 to Nov 2024
Arrayit (CE) (USOTC:ARYC)
Historical Stock Chart
From Nov 2023 to Nov 2024
